CN Patent

CN102391267A — 8-(3-氨基-哌啶-1-基)-黄嘌呤、其制备方法及其用途

Assigned to Boehringer Ingelheim International GmbH · Expires 2012-03-28 · 14y expired

What this patent protects

本发明涉及8-(3-氨基哌啶-1-基)-黄嘌呤、其制备方法及其用途。

USPTO Abstract

本发明涉及8-(3-氨基哌啶-1-基)-黄嘌呤、其制备方法及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102391267A
Jurisdiction
CN
Classification
—
Expires
2012-03-28
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.